Skip to main
SLQT

SelectQuote (SLQT) Stock Forecast & Price Target

SelectQuote (SLQT) Analyst Ratings

Based on 2 analyst ratings
Hold
Strong Buy 0%
Buy 0%
Hold 100%
Sell 0%
Strong Sell 0%

Bulls say

SelectQuote Inc. benefits from its Healthcare Services segment, which provides high revenue visibility and favorable economic characteristics, contributing to a strengthened risk profile for the company. The growth estimate for Medicare Advantage (MA) approved policies has been revised upward to 6.5% for fiscal 2026, indicating an anticipated increase in consumer shopping behavior and strategic investments in staffing. This combination of strong segment performance and positive growth metrics supports a favorable outlook for SelectQuote's stock.

Bears say

SelectQuote Inc. is facing significant challenges due to a reduction in headcount, which has contributed to a projected 3.9% decline in approved Medicare Advantage memberships for fiscal year 2025. Additionally, the company risks encountering persisting headwinds, which may lead to negative tail-revenue and decreased cash flow from commissions, with an estimated 20% headwind to adjusted EBITDA. Overall, these factors indicate a deteriorating financial outlook for SelectQuote, underlining the company's vulnerabilities in its operational and revenue-generating capabilities.

SelectQuote (SLQT) has been analyzed by 2 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 0% recommend Buy, 100% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SelectQuote and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SelectQuote (SLQT) Forecast

Analysts have given SelectQuote (SLQT) a Hold based on their latest research and market trends.

According to 2 analysts, SelectQuote (SLQT) has a Hold consensus rating as of Dec 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $3.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $3.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SelectQuote (SLQT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.